PROVIDE-HF primary results: Patient-Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (sacubitril/valsartan) in heart failure
Year: 2020
Type: article
Study design: Observational Study
Source: American Heart Journal
Authors: Robert J. Mentz, Haolin Xu, Emily C. O'Brien, Laine Thomas, Tamas Alexy, Bhanu Gupta, Juan Vilaro, Anuradha Lala, Adam D. DeVore, Ravi Dhingra, Alexandros Briasoulis, Marc A. Simon, Josef Stehlik, Jo E. Rodgers, Shannon M. Dunlay, Martha Abshire, Quinn S. Wells, Kurt G. Barringhaus, Peter M. Eckman, Brian D. Lowes, Johana Espinoza, Rosalia Blanco, Xian Shen, Carol I. Duffy, Adrian F. Hernandez
Institutions: Duke University, Duke Medical Center, University of Minnesota, University of Kansas Medical Center, University of Florida, Icahn School of Medicine at Mount Sinai, University of Wisconsin–Madison, University of Iowa Hospitals and Clinics, University of Pittsburgh, McGowan Institute for Regenerative Medicine, University of Utah, University of North Carolina at Chapel Hill, Mayo Clinic, Johns Hopkins University, Vanderbilt University Medical Center, University of South Carolina, Wm. Jennings Bryan Dorn VA Medical Center, University of Nebraska Medical Center
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G920751844
OpenAlex ID: W3088201962